GOLDEN BIOTECHNOLOGY CORP financial statements, including revenue, expenses, profit, and loss
The total revenue of 4132 for the last semiannual is 34.54 M TWD, and it's 19.55% higher compared to the previous semiannual. The net income of H2 23 is -218.52 M TWD.